Results 81 to 90 of about 20,336 (222)

The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease

Journal of Cell Communication and Signaling, Volume 20, Issue 1, March 2026.
Abstract FGF23 excess is associated with morbidity and mortality, but the role of excessive circulating FGF23 concentrations as a causative factor of pathology is controversial. Here, we investigated the consequences of FGF23 excess in kidney disease. This study used three disease models: anti‐glomerular basement membrane (anti‐GBM) disease, Adriamycin
Matthias B. Moor, Mikhail Burmakin, Anna Levin, Gül Gizem Korkut, David Brodin, Annika Wernerson, Annette Bruchfeld, Peter Bárány, Anna Witasp, Jaakko Patrakka, Hannes Olauson   +10 more
wiley   +1 more source

Efficacy of a Once-Daily Supplement in Managing Canine Chronic Kidney Disease

Animals
Background: Chronic kidney disease (CKD) in companion animals leads to progressive renal deterioration and metabolic complications such as hyperphosphatemia and metabolic acidosis, particularly in advanced stages.
Francesca Perondi, Alessio Ruggiero, Monica Isabella Cutrignelli, Ilaria Lippi, Giorgia Meineri, Elisa Martello   +5 more
doaj   +1 more source

The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease [PDF]

Терапевтический архив, 2016
Aim. To study whether the excessive production of serum fibroblast growth factor 23 (FGF-23) may be reduced with phosphate-binding agents to treat hyperphosphatemia in patients with Stage VD chronic kidney disease (CKD). Subjects and methods.
N A Mukhin, Yu S Milovanov, L V Kozlovskaya, I A Dobrosmyslov, L Yu Milovanova   +4 more
doaj  

Clinical Relevance and Diagnostic Utility of Standard Serum Biomarkers in Advanced Chronic Kidney Disease: A Single‐Center Observational Study From Bangladesh

iLABMED, Volume 4, Issue 1, Page 27-36, March 2026.
This study evaluated conventional and emerging biochemical markers for assessing chronic kidney disease (CKD) progression in Bangladeshi patients elevated serum uric acid and parathyroid hormone levels, along with reduced eGFR, vitamin D, and albumin levels, were significantly associated with CKD, highlighting their potential as cost‐effective early ...
Fazlul Haque, Md. Samiul Islam, Nafsoon Rahman, Ayub Zawad, Sadia Afrin, Pulak Kanti Palit, Tanjil Hasan, Md. Isahak Ali, Shafin Ahmed, Akram Hossain, Marina Khatun, Tabassuma Marzia Prome, Md. Shah Alam, Ashekul Islam   +13 more
wiley   +1 more source

Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines [PDF]

, 2005
Childhood renal osteodystrophy (ROD) is the consequence of disturbances of the calcium-regulating hormones vitamin D and parathyroid hormone (PTH) as well as of the somatotroph hormone axis associated with local modulation of bone and growth cartilage ...
G. Klaus, A. Watson, A. Edefonti, M. Fischbach, K. Rönnholm, F. Schaefer, E. Simkova, C. J. Stefanidis, V. Strazdins, J. Vande Walle, C. Schröder, A. Zurowska, M. Ekim, Oh, Watson, Schroder, Fischbach, Schroder, Blind, Gao, Reichel, Waller, Salusky, Lefebvre, Carbajo, Kalhoff, Kovacic, Feriani, Coburn, K, Norman, Slatopolsky, Kilav, Naveh-Many, Almaden, Portale, Yi, Milliner, Block, Huting, Ribeiro, Moe, Amann, Coleman, Schaefer, Fischbach, Maasrani, Bell, Maduell, Traeger, Fischbach, Fischbach, Fischbach, Schiller, Wallot, Pflanz, Lowrie, Fernandez-Gavarron, Reichel, Dusso, Van, Birge, Ritz, Waller, Salusky, Piscitelli, Klaus, Ballanti, Kuizon, Shigematsu, Ardissino, Tsuruoka, Goodman, Klaus, Mehls, Schmitt, Ardissino, Herrmann, Sprague, Block, Haffner, Wang, Olney, Loder, Fine, Berard, Picca, Fukagawa, Okuno, Kakuta, Quarles   +90 more
core   +1 more source

Alkaline Phosphatase and Infantile GM1 Gangliosidosis: A Simple Biomarker for a Complex Disease?

JIMD Reports, Volume 67, Issue 2, March 2026.
ABSTRACT GM1 gangliosidosis is a lysosomal storage disease (LSD) caused by β‐galactosidase deficiency, characterized by the accumulation of gangliosides in various tissues. Among different GM1 forms (infantile form, late‐infantile and juvenile form, and late‐onset form), the infantile form is the most severe: despite an early clinical onset with rapid ...
Laura Fiori, Massimiliano Turzi, Veronica Maria Tagi, Laura Asnaghi, Eleonora Bonaventura, Davide Tonduti, Luigina Spaccini, Laura Assunta Saielli, Chiara Montanari, Francesca Cairello, Savina Mannarino, Matilde Ferrario, Alessandra Del Longo, Marcello Napolitano, Andrea Righini, Michela Semeraro, Anna Venerando, Martina Miceli, Elvira Verduci, Gianvincenzo Zuccotti   +19 more
wiley   +1 more source

Hypophosphatemia and Hyperphosphatemia

Critical Care Clinics, 1991
Pathophysiology, clinical sequelae, and treatment for hypophosphatemia and hyperphosphatemia are discussed. Hypophosphatemia results from a variety of conditions including malnutrition, carbohydrate refeeding, acid-base disorders, and hormonal and drug effects. Patients suffering from severe hypophosphatemia may present with a variety of syndromes that
Michael P. Peppers, Michael Geheb, Tusar Desai   +2 more
openaire   +3 more sources

Hipoparatiroidismo e pseudohipoparatiroidismo [PDF]

, 2006
The principal function of the parathyroid hormone (PTH) is maintenance of calcium plasmatic levels, withdrawing the calcium from bone tissue, reabsorbing it from the glomerular filtrate, and indirectly increasing its intestinal absorption by stimulating ...
Borba, Victoria Zeghbi Cochenski, Fortes, Erika M., Lazaretti-Castro, Marise, Maeda, Sergio Setsuo, Oliveira, Ulisses M.   +4 more
core   +3 more sources

Targeting Delivery of Cyanidin‐Loaded With Ti3C2 Nanosheets for Alleviating Vascular Calcification in Chronic Kidney Disease

MedComm – Biomaterials and Applications, Volume 5, Issue 1, March 2026.
Vascular calcification significantly elevates cardiovascular risk in CKD patients, yet no effective therapies exist to halt its progression. We developed a dual targeting nanoplatform Ti3C2/RANKL/OCN/Cyanidin (TROC) for the targeted delivery of cyanidin against vascular calcification.
Li Yin, Xiaoge Zhang, Huanji Zhang, Changming Xie, Zhengzhipeng Zhang, Dong Wang, Yuning Liu, Bing Dong, Leilei Shi, Jie Liu, Hui Huang   +10 more
wiley   +1 more source

Nutrition Support in Acute Kidney Injury [PDF]

, 2011
Acute kidney injury is a frequent complication affecting many hospitalized patients and is associated with increased morbidity and mortality. Acute kidney injury often occurs in conjunction with critical illness, which is a hypermetabolic state ...
Alkhunaizi AM, Berger MM, Canada TW, Druml W, Druml W, Feinstein EI, Fiaccadori E, Fiaccadori E, Fiaccadori E, Gleghorn EE, Ikizler TA, Jane M. Gervasio, Li Y, Michael Holowatyj, Schneeweiss B, Wesley P. Garmon   +15 more
core   +2 more sources